Acute cardiodepressant effects induced by bolus intravenous administration of amiodarone in rabbits

Fundamental and Clinical Pharmacology

Volumn 19, Issue 2, 2005, Pages 165-172

  Lessa, Marcos Adriano ^a   Tibiriçá, Eduardo ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Amiodarone; Cardiac output; Cardiodepression; Lidocaine

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; LIDOCAINE; PENTOBARBITAL;

ANIMAL EXPERIMENT; ARTICLE; BOLUS INJECTION; CARDIOVASCULAR DEPRESSION; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE RELAXATION; HEART OUTPUT; HEART RATE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HEMODYNAMICS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SYSTEMIC VASCULAR RESISTANCE;

AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; BLOOD PRESSURE; CARDIAC OUTPUT; FEMALE; HYPOTENSION; INJECTIONS, INTRAVENOUS; LIDOCAINE; MALE; MYOCARDIAL CONTRACTION; RABBITS;

EID: 17144417697     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2004.00308.x     Document Type: Article

References (47)

1. Auer J., Berent R., Eber B. Amiodarone in the prevention and treatment of arrhythmia. Curr. Opin. Invest. Drugs (2002) 3 1037-1044.
2. Burkart F., Pfisterer M., Kiowski W., Follath F., Burckhardt D. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS). J. Am. Coll. Cardiol. (1990) 16 1711-1718.
3. Cairns J.A., Connolly S.J., Roberts R., Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet (1997) 349 675-682.
4. Julian D.G., Camm A.J., Frangin G. et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet (1997) 349 667-674.
5. Singh B.N., Sarma J.S.M. Amiodarone and amiodarone derivates, in: Singh B.N., Dzau V.J., Vanhoutte P.M., Woosley R.L. (Eds). Cardiovascular pharmacology and therapeutics. Churchill Livingstone. New York, 1994, pp. 689-710.
6. Gill J., Heel R.C., Fitton A. Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias. Drugs (1992) 43 69-110.
7. Monassier L., Bousquet P. Sigma receptors: from discovery to highlights of their implications in the cardiovascular system. Fundam. Clin. Pharmacol. (2002) 16 1-8.
8. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation (ILCOR). Pharmacology I: agents for arrhythmias. Circulation (2000) 102 I112-I128.
9. Cheung A.T., Weiss S.J., Savino J.S. et al. Acute circulatory actions of intravenous amiodarone loading in cardiac surgical patients. Ann. Thorac. Surg. (2003) 76 535-541.
10. Shieh J.P., Chu C.C., Chen J.Y., Chen Y.H., Yeh F.C., Hsing C.H. Acute fatal vasoplegia and asystole induced by intravenous amiodarone after cardiopulmonary bypass in a patient with preoperative cardiogenic shock. Acta Anaesthesiol. Sin. (1999) 37 205-210.
11. Munoz A., Karila P., Gallay P. et al. A randomized hemodynamic comparison of intravenous amiodarone with and without Tween 80. Eur. Heart J. (1988) 9 142-148.
12. Remme W.J., van Hoogenhuyze D.C., Kruyssen D.A., Krauss X.H., Storm C.J. Amiodarone. Haemodynamic profile during intravenous administration and effect on pacing-induced ischaemia in man. Drugs (1985) 29 11-22.
13. Twidale N., Roberts-Thomson P., McRitchie R.J., Chalmers J.P. Comparative haemodynamic effects of verapamil, flecainide, amiodarone and sotalol in the conscious rabbit. Clin. Exp. Pharmacol. Physiol. (1994) 21 179-188.
14. Sugiyama A., Satoh Y., Hashimoto K. Acute electropharmacological effects of intravenously administered amiodarone assessed in the in vivo canine model. Jpn. J. Pharmacol. (2001) 87 74-82.
15. Cinelli P., Romano S., Castaldo G., de Scalzi M., Citi S., de Leonardis V. Computerized M-mode echocardiography in the assessment of cardiovascular effects during intravenous administration of amiodarone. Methods Find. Exp. Clin. Pharmacol. (1984) 6 27-32.
16. Tande P.M., Refsum H. Class III antiarrhythmic action linked with positive inotropy: acute electrophysiological and inotropic effects of amiodarone in vitro. Pharmacol. Toxicol. (1990) 66 18-22.
17. 7 Kudenchuk P.J., Cobb L.A., Copass M.K. et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N. Engl. J. Med. (1999) 341 871-878.
18. Dorian P., Cass D., Schwartz B., Cooper R., Gelaznikas R., Barr A. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N. Engl. J. Med. (2002) 346 884-890.
19. Kevber R.E., Kudenchuk P.J., Berg R.A. et al. Guidelines 2000 for cardiopulmonary resuscitation, and emergency cardio vascular care. Part 6: advanced cardiovascular life support: The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Circulation (2000) 102 I86-I171.
20. Hoffmeister H.M., Beyer M.E., Seipel L. Hemodynamic effects of antiarrhythmic compounds: intrinsic effects and autonomic modulation. Am. J. Cardiol. (1997) 80 24G-30G.
21. Takada K., Sumikawa K., Kamibayashi T. et al. Comparative efficacy of antiarrhythmic agents in preventing halothane-epinephrine arrhythmias in rats. Anesthesiology (1993) 79 563-570.
22. Platou E.S., Refsum H. Class III antiarrhythmic action in experimental atrial fibrillation and flutter in dogs. J. Cardiovasc. Pharmacol. (1982) 4 839-846.
23. Winslow E. Hemodynamic and arrhythmogenic effects of aconitine applied to the left atria of anesthetized cats. Effects of amiodarone and atropine. J. Cardiovasc. Pharmacol. (1981) 3 87-100.
24. Wirth K.J., Knobloch K. Differential effects of dofetilide, amiodarone, and class 1c drugs on left and right atrial refractoriness and left atrial vulnerability in pigs. Naunyn Schmiedebergs Arch. Pharmacol. (2001) 363 166-174.
25. Bacq Z.M., Blakeley A.G., Summers R.J. The effects of amiodarone, an alpha and beta receptor antagonist, on adrenergic transmission in the cat spleen. Biochem. Pharmacol. (1976) 15 1195-1199.
26. Follmer C.H., Aomine M., Yeh J.Z., Singer D.H. Amiodarone-induced block of sodium current in isolated cardiac cells. J. Pharmacol. Exp. Ther. (1987) 243 187-194.
27. Singh B.N., Venkatesh N., Nademanee K., Josephson M.A., Kannan R. The historical development, cellular electrophysiology and pharmacology of amiodarone. Prog. Cardiovasc. Dis. (1989) 31 249-280.
28. Scheinman M.M., Levine J.H., Cannom D.S. et al. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. Circulation (1995) 92 3264-3272.
29. Gallik D.M., Singer I., Meissner M.D., Molnar J., Somberg J.C. Hemodynamic and surface electrocardiographic effects of a new aqueous formulation of intravenous amiodarone. Am. J. Cardiol. (2002) 90 964-968.
30. Cough W.B., Zeiler R.H., Barreca P., El-Sherif N. Hypotensive action of commercial intravenous amiodarone and polysorbate 80 in dogs. J. Cardiovasc. Pharmacol. (1982) 4 375-380.
31. Sicart M., Besse P., Choussat A., Bricaud H. Action hemodynamique de l'amiodarone intra-veineuse chez l'homme. Arch. Mal. Coeur. Vaiss. (1977) 70 219-227.
32. Seipel L., Hoffmeister H.M. Hemodynamic effects of anti-arrhythmic drugs: negative inotropy versus influence on peripheral circulation. Am. J. Cardiol. (1989) 64 37J-40J.
33. Gotzsche LB. Acute increase in cardiac performance after triiodothyronine: blunted response in amiodarone-treated pigs. J. Cardiovasc. Pharmacol. (1994) 23 141-148.
34. Tabayashi K., Misbach G.A., Miyamoto M. et al. Hemodynamic effects of oral amiodarone on left ventricular function before and after global ischemia. J. Surg. Res. (1992) 52 271-275.
35. Ware W.A., Muir W.W., Swanson C. Effects of amiodarone on myocardial performance in normal canine hearts and canine hearts with infarcts. Am. J. Vet. Res. (1991) 52 891-897.
36. Karlson I.A., Hopkins R.W., Moran J.M., Karlson K.E. Long-term amiodarone administration protects against global myocardial ischemia. Ann. Thorac. Surg. (1990) 50 575-578.
37. Nokin P., Jungbluth L., Mouton J. Protective effects of amiodarone pretreatment on mitochondrial function and high energy phosphates in ischaemic rat heart. J. Mol. Cell. Cardiol. (1987) 19 603-614.
38. Riva E., Hearse D.J. Anti-arrhythmic effects of amiodarone and desethylamiodarone on malignant ventricular arrhythmias arising as a consequence of ischaemia and reperfusion in the anaesthetised rat. Cardiovasc. Res. (1989) 23 331-339.
39. Sano T., Sugiyama S., Taki K. et al. Effects of antiarrhythmic agents classified as class III group on ischaemia-induced myocardial damage in canine hearts. Br. J. Pharmacol. (1990) 99 577-581.
40. DeBoer L.W., Nosta J.J., Kloner R.A., Braunwald E. Studies of amiodarone during experimental myocardial infarction: beneficial effects on hemodynamics and infarct size. Circulation (1982) 65 508-512.
41. Cote P., Bourassa M.G., Delaye J., Janin A., Froment R., David P. Effects of amiodarone on cardiac and coronary hemodynamics and on myocardial metabolism in patients with coronary artery disease. Circulation (1979) 59 1165-1172.
42. Pfisterer M., Burkart F., Muller-Brand J., Kiowski W. Important differences between short- and long-term hemodynamic effects of amiodarone in patients with chronic ischemic heart disease at rest and during ischemia-induced left ventricular dysfunction. J. Am. Coll. Cardiol. (1985) 5 1205-1211.
43. Remme W.J., Van Hoogenhuyze D.C., Krauss X.H., Hofman A., Kruyssen D.A., Storm C.J. Acute hemodynamic and antiischemic effects of intravenous amiodarone. Am. J. Cardiol. (1985) 55 639-644.
44. Deleixhe A., Delree G. A new anti-angina substance: amiodarone. Rev. Med. Liege. (1969) 24 377-380.
45. Facquet J., Nivet M., Alhomme P., Raharison S., Grosgogeat Y. Treatment of angina pectoris with amiodarone. Presse Med. (1969) 77 725-726.
46. Leutenegger A., Luthy E. A new substance in the therapy of angina pectoris: amiodarone. Schweiz. Med. Wochenschr. (1968) 98 2020-2025.
47. Nivet M. Amiodarone: new treatment of angina pectoris. Therapeutique (1968) 44 551-554.